000			01994 a2200625 4500
005			20250517102848.0
264		0	_c20171101
008			201711s 0 0 eng d
022			_a1365-2893
024	7		_a10.1111/jvh.12553 _2doi
040			_aNLM _beng _cNLM
100	1		_aKawakami, Y
245	0	0	_aPharmacokinetics, efficacy and safety of daclatasvir plus asunaprevir in dialysis patients with chronic hepatitis C: pilot study. _h[electronic resource]
260			_bJournal of viral hepatitis _c11 2016
300			_a850-856 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aCarbamates
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aHepatitis C, Chronic _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImidazoles _xadministration & dosage
650	0	4	_aIncidence
650	0	4	_aIsoquinolines _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPilot Projects
650	0	4	_aProspective Studies
650	0	4	_aPyrrolidines
650	0	4	_aRenal Dialysis
650	0	4	_aRenal Insufficiency _xcomplications
650	0	4	_aSulfonamides _xadministration & dosage
650	0	4	_aSustained Virologic Response
650	0	4	_aTreatment Outcome
650	0	4	_aValine _xanalogs & derivatives
700	1		_aImamura, M
700	1		_aIkeda, H
700	1		_aSuzuki, M
700	1		_aArataki, K
700	1		_aMoriishi, M
700	1		_aMori, N
700	1		_aKokoroishi, K
700	1		_aKatamura, Y
700	1		_aEzaki, T
700	1		_aUeno, T
700	1		_aIde, K
700	1		_aMasaki, T
700	1		_aOhdan, H
700	1		_aChayama, K
773	0		_tJournal of viral hepatitis _gvol. 23 _gno. 11 _gp. 850-856
856	4	0	_uhttps://doi.org/10.1111/jvh.12553 _zAvailable from publisher's website
999			_c26163397 _d26163397